HLS Therapeutics Inc at Stifel Virtual Healthcare Conference Transcript
Good afternoon, everyone, and thank you for joining our fireside chat with HLS Therapeutics. I'm Justin Keywood, a health care analyst at Stifel, and I'll be moderating the chat.
We're going to start with a brief introduction to management and the company. And then we'll just jump right into the discussion and Q&A. For those of you online, you do have the ability to ask questions throughout the 30-minute presentation here, and we'll try to fit in as many as we can.
But as you can see, the slide that we have up, HLS, it's about a $500 million market cap company, specialty health care business in the CNS and cardiovascular space. From HLS, joining us today, we have the Chief Executive Officer and Co-Founder, Gilbert Godin; and Chief Financial Officer, Tim Hendrickson. Thank you, gentlemen, for both joining and congratulations on all the recent success.
And I'll turn it over to Gilbert for a brief overview of the business. Thank you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |